Back to Search Start Over

P2.19-01 First-in-Human Phase 1 Trial of VT3989, a First-in-Class YAP/TEAD Inhibitor in Patients with Advanced Mesothelioma

Authors :
Yap, T.
Desai, J.
Dagogo-Jack, I.
Millward, M.
Kindler, H.L.
Tolcher, A.W.
Frentzas, S.
Body, A.L.
Thurston, A.
Post, L.
Dorr, F.A.
Kwiatkowski, D.J.
Source :
Journal of Thoracic Oncology; November 2023, Vol. 18 Issue: 11, Number 11 Supplement 1 pS384-S384, 1p
Publication Year :
2023

Details

Language :
English
ISSN :
15560864 and 15561380
Volume :
18
Issue :
11, Number 11 Supplement 1
Database :
Supplemental Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Periodical
Accession number :
ejs64381830
Full Text :
https://doi.org/10.1016/j.jtho.2023.09.680